Pay in 4 interest-free payments of $5.38 Learn more
Ships within 48 hours · Estimated delivery Aug 13 - Aug 18
Mounjaros established track record in clinical practice provides confidence in its long-term efficacy and safety profile
Weight-loss medications are the most commonly excluded category
The earliest realistic date is 2029, and only if NICE believes it to be cost-effective
At Embla, we help employers deliver better weight loss outcomes with less medication, fewer side effects, and more sustainable results.Talk to our team tolearn how we help self-funded employers launch structured, high-impact GLP-1 benefits
For those who prefer a lower-effort approach, our analysis of losing weight on semaglutide without exercise examines what is realistically achievable with medication alone
For individuals seeking evidence-based weight management support, NICE recommends a structured approach incorporating dietary intervention, physical activity, and behavioural support, with pharmacotherapy considered where appropriate within NHS tiered weight management services
US$ 20.55
US$ 28.24
US$ 27.05
US$ 20.38
